{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:26:36Z","timestamp":1790375196224,"version":"4.1.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1001\/jamacardio.2017.3944","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T12:32:40Z","timestamp":1510144360000},"page":"1385","source":"Crossref","is-referenced-by-count":95,"title":["Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin"],"prefix":"10.1001","volume":"2","author":[{"given":"Robert P.","family":"Giugliano","sequence":"first","affiliation":[{"name":"TIMI (Thrombolysis in Myocardial Infarction) Study Office, Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Keech","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council Clinical Trials Centre, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"TIMI (Thrombolysis in Myocardial Infarction) Study Office, Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Cardiology, and Intensive Care Medicine, Faculty of Medicine, Sigmund Freud University, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lale","family":"Tokgozoglu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil S.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital de Santa Cruz, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando Lira","family":"Pineda","sequence":"additional","affiliation":[{"name":"Amgen, Inc, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ransi","family":"Somaratne","sequence":"additional","affiliation":[{"name":"Amgen, Inc, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Sever","sequence":"additional","affiliation":[{"name":"International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje R.","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Ullev\u00e5l and Medical Faculty, Oslo University Hospital, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[{"name":"TIMI (Thrombolysis in Myocardial Infarction) Study Office, Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Deputy Editor, JAMA Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.3944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T17:05:43Z","timestamp":1513789543000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.3944"}},"subtitle":["Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2017.3944","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732097899.793544546","asserted-by":"object"}]},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}